BioSpace News Archive

Piramal Pharma Limited’s Critical Care business, a leading Complex Hospital Generics company, announces First to Market Generic U.S. launch of Zinc Sulfate Injection.

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announces that it has initiated rolling submission of the Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) seeking approval of the Company’s single-shot chikungunya vaccine candidate in persons aged 18 years and above.

Gestalt Diagnostics and Voicebrook today announced a strategic partnership to benefit information flow and technology interactions in the pathology laboratory.

Several advances in the field of biotechnology, particularly antibody engineering has led to designing of next generation therapeutics with more enhanced efficacy and safety.

According to the report, the global autoimmune disease diagnostics market was valued at US$ 14.4 Bn in 2021 and is anticipated to expand at a CAGR of 3.8% from 2022 to 2030.

Dermaliq Therapeutics, Inc. today announced first patient dosed in a Phase 1b/2a trial with DLQ02, a topical calcineurin inhibitor.

This report profiles major players in the global bilirubin meters market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments

Advancements across various facets of the medical sector have occurred at a rapid pace over the past couple of decades, due to technological innovations and research activities.

SPIE, the international society for optics and photonics, and IBM Quantum have selected Wesley Sims, an assistant professor of physics at Morehouse College, as this year’s recipient of the IBM-SPIE HBCU Faculty Accelerator Award in Quantum Optics and Photonics.

According to the report, the global cord blood banking services market was valued at US$ 25.8 Bn in 2021 and is anticipated to expand at a CAGR of 10.9% from 2022 to 2030.